Pfizer has entered into a research collaboration with deCODE genetics to discover sequence variants associated with specific clinical phenotypes related to Systemic Lupus Erythematosis using deCODE’s gene discovery expertise. During the next 18 months, the two companies will work together to analyze patient genomes to search for sequence variants that would be useful for understanding drug targets and discovering novel drug targets, which may lead to tools for patient stratification and c...